USFDA completes inspection at Stride Pharma with zero observation

The company has set a target to launch approximately 20 new products every year in the US.

1131

Last Updated on December 31, 2023 by The Health Master

Strides Pharma’s formulation facility in Singapore underwent a US Food and Drug Administration (USFDA) inspection that ended yesterday.

The inspection was completed successfully with Zero observations on Form 483, a statement from Strides Pharma said.

The US is one of the key focus markets for Strides and the company has given a growth outlook of $250 million in FY23 for the US business.

The company has set a target to launch approximately 20 new products every year in the US.

It has 279 cumulative ANDA filings (including a recently acquired portfolio from Endo at Chestnut Ridge) with USFDA of which 259 ANDAs have been approved and 20 are pending approval.

The company has a diversified manufacturing base with five FDA-approved facilities which are capable of catering to multiple dosage formats, including niche capabilities in controlled substances, hormones, nasal sprays, gels, modified release products, and liquids.

USFDA issues Form 483 for 6 observations to Jubilant Pharmova

USFDA issues Form 483 for 3 observations to Aurobindo Pharma

USFDA completes inspection of Casper Pharma with Zero Observations

USFDA issues Form 483 for six observations to Granules Pharma

USFDA issues Form 483 for 3 observations to Biocon for Telangana plant

USFDA issues 2 observations to Cipla Indore Plant

FIR registered under Drugs and Magic Remedies Act 1954

USFDA gives final approval for Adapalene and Benzoyl Peroxide Topical Gel

IPC flags safety alert against immunosuppressive drug Tacrolimus

Govt to Create 219 Jobs for Drug Inspectors, Senior Officials to regulate Medical Devices in India

FDA raided: Fake Cosmetic manufacturing factory busted

PCI should revise B Pharm curriculum as per NEP 2020: Expert

FDA Haryana busted a fake medicine factory

FDA Maharashtra seizes diagnostic kits being sold without license

Govt is set to ban Codeine-based Cough Syrups and formulations

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news